Skip to main content

Table 4 The values of β, hazard ratio and P values in Cox multivariate regression model disease-free survival

From: Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

   β Hazard ratio P value
LR Clinical T stage (3 vs. 4) 1.23 3.43 0.05
DFS TRG score (3/4 vs. 1/2) 1.36 3.90 0.00
  Clinical T stage (3 vs. 4) 1.11 3.04 0.01
  1. LR: local recurrence.
  2. DFS: disease-free survival.
  3. TRG: tumor regression grade.